CPIX...$3.70...Off the $2.15 Alert...🥳
georgie18
Member Level
Re: georgie18 post# 116
Tuesday, February 04, 2025 3:51:03 PM
Post#
119
of 119
CPIX...$3.33 Later day traction...🥳
georgie18
Member Level
Re: georgie18 post# 671313
Tuesday, February 04, 2025 7:46:43 AM
Post#
673199
of 673320
CPIX...$2.53...🥳... NASHVILLE, Tenn., Feb. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on new products for rare diseases, today announced positive top-line results from its Phase 2 FIGHT DMD trial. The study evaluated ifetroban, a novel oral therapy for Duchenne muscular dystrophy (DMD) heart disease – the leading cause of death in DMD patients. It marks a breakthrough for these patients, as it's the first successful Phase 2 study specifically targeting the cardiac complications of their condition.
georgie18
Member Level
Re: georgie18 post# 113
Tuesday, January 14, 2025 3:24:40 PM
Post#
114
of 116
CPIX...$3.20...🥳...$3.93 was HOD...
georgie18
Member Level
Re: georgie18 post# 671304
Tuesday, January 14, 2025 3:06:24 PM
Post#
671311
of 671312
CPIX...$3.04...🥳...on the Breakout...
georgie18
Member Level
Re: georgie18 post# 108
Tuesday, January 14, 2025 2:48:25 PM
Post#
112
of 112
CPIX...$2.90s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 668192
Tuesday, January 14, 2025 12:10:07 PM
Post#
671291
of 671303
CPIX...$2.77...🥳...Hit $3.93 on the Channel Breakout...
georgie18
Member Level
Re: georgie18 post# 103
Wednesday, December 18, 2024 2:05:56 PM
Post#
105
of 107
CPIX...$2.33...Trying to Reverse here...🥳
georgie18
Member Level
Re: georgie18 post# 667357
Tuesday, December 10, 2024 8:16:14 AM
Post#
667359
of 668190
CPIX...$3.07...🥳...Off my $2.15 Alert...
georgie18
Member Level
Re: georgie18 post# 97
Tuesday, December 10, 2024 8:12:33 AM
Post#
102
of 102
CPIX...$2.71...🥳...Off my $2.15 Alert...
georgie18
Member Level
Re: georgie18 post# 667334
Monday, December 09, 2024 4:26:19 PM
Post#
667337
of 667357
CPIX...$2.27...🥳
georgie18
Member Level
Re: None
Monday, December 09, 2024 4:19:53 PM
Post#
96
of 96
CPIX...$2.15...🥳...NASHVILLE, Tenn., Dec. 9, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced today the FDA has approved a supplemental New Drug Application (sNDA) for its Acetadote® (N-acetylcysteine for injection) product. Acetadote is an intravenous (IV) formulation of N-acetylcysteine (NAC) indicated to prevent or lessen liver injury after ingestion of potentially toxic quantities of acetaminophen1.